SeekingAlpha News Releases and Press Releases From 07/20/24

2024-07-20 04:00:00 ET Summary The European Central Bank’s July monetary policy meetings tend to be uneventful, and this year proved no exception. Given the ECB’s reaction function, we expect the ECB to continue lowering rates at staff projection meetings and therefo...

2024-07-20 04:00:00 ET Summary The European Central Bank’s July monetary policy meetings tend to be uneventful, and this year proved no exception. Given the ECB’s reaction function, we expect the ECB to continue lowering rates at staff projection meetings and therefo...

2024-07-20 04:00:00 ET Summary The European Central Bank’s July monetary policy meetings tend to be uneventful, and this year proved no exception. Given the ECB’s reaction function, we expect the ECB to continue lowering rates at staff projection meetings and therefo...

2024-07-20 04:00:00 ET Summary The European Central Bank’s July monetary policy meetings tend to be uneventful, and this year proved no exception. Given the ECB’s reaction function, we expect the ECB to continue lowering rates at staff projection meetings and therefo...

2024-07-20 04:00:00 ET Summary The European Central Bank’s July monetary policy meetings tend to be uneventful, and this year proved no exception. Given the ECB’s reaction function, we expect the ECB to continue lowering rates at staff projection meetings and therefo...

2024-07-20 04:00:00 ET Summary The European Central Bank’s July monetary policy meetings tend to be uneventful, and this year proved no exception. Given the ECB’s reaction function, we expect the ECB to continue lowering rates at staff projection meetings and therefo...

2024-07-20 04:00:00 ET Summary The European Central Bank’s July monetary policy meetings tend to be uneventful, and this year proved no exception. Given the ECB’s reaction function, we expect the ECB to continue lowering rates at staff projection meetings and therefo...

2024-07-20 03:50:03 ET Summary The company continues to deliver strong turnover growth and core margin expansion. Ongoing buyback combined with a juicy dividend yield provides downside protection. Positive contributions from newer drug launches. Novartis raised the 2024 core o...

2024-07-20 03:50:03 ET Summary The company continues to deliver strong turnover growth and core margin expansion. Ongoing buyback combined with a juicy dividend yield provides downside protection. Positive contributions from newer drug launches. Novartis raised the 2024 core o...

2024-07-20 03:37:54 ET Summary VYM prices were largely trapped in a consolidation window between $110 and $120 in the past ~3 years or so. Catalysts developed recently are finally pushing it out of this multi-year trading window. The top catalysts are the updated probabil...